Liezl Gambe

Injective (INJ) CEO Eric Chen expects US ETFs tied to INJ to launch before 2027, according to an exclusive report by The Block.

Venari Minerals (ASX:VMS) has confirmed the addition of strontium and magnesium by-products to its updated resource estimate at the flagship Red Mountain Project.

Rumble Resources (ASX:RTR) announced operational progress at its Western Queen Project, targeting a final decision to mine in the December quarter.

Macquarie (ASX:MQG) will review its board conflict of interest policy following an investigation into KPMG's handling of confidential information during a recent audit tender.

Andromeda Metals (ASX:ADN) secured its first patent from the Republic of South Africa for its alumina extraction process.

China’s crypto economy reached an estimated $176.3 billion between July 2025 and June 2026, according to Chainalysis.

Astral Resources (ASX:AAR) entered into a formal binding agreement with Estrella Resources (ASX:ESR) to acquire 100% of its Spargoville Nickel Rights.

New Zealand insurer Tower (ASX:TWR) raised its full-year underlying net profit forecast to between NZ$69 million and NZ$79 million.

Datasea (NASDAQ:DTSS) released its full-year financial performance for the period ending June 30, 2026, highlighting improved profitability metrics alongside top-line adjustments.

Abbott (NYSE:ABT) received regulatory clearance from the U.S. Food and Drug Administration for major software capabilities connected to its implanted heart-monitoring platform.